JP7663359B2 - 変性エラスチンの分解低下の抑制剤、正常なエラスチン線維の維持剤、エラスチン-エラフィン複合体形成抑制剤及びエラスチン-エラフィン複合体形成抑制作用を有する物質のスクリーニング方法 - Google Patents

変性エラスチンの分解低下の抑制剤、正常なエラスチン線維の維持剤、エラスチン-エラフィン複合体形成抑制剤及びエラスチン-エラフィン複合体形成抑制作用を有する物質のスクリーニング方法 Download PDF

Info

Publication number
JP7663359B2
JP7663359B2 JP2020563279A JP2020563279A JP7663359B2 JP 7663359 B2 JP7663359 B2 JP 7663359B2 JP 2020563279 A JP2020563279 A JP 2020563279A JP 2020563279 A JP2020563279 A JP 2020563279A JP 7663359 B2 JP7663359 B2 JP 7663359B2
Authority
JP
Japan
Prior art keywords
elastin
extract
elafin
formation
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020563279A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020138023A1 (ja
Inventor
壮太 赤澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of JPWO2020138023A1 publication Critical patent/JPWO2020138023A1/ja
Priority to JP2023060120A priority Critical patent/JP2023078477A/ja
Application granted granted Critical
Publication of JP7663359B2 publication Critical patent/JP7663359B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/577Malvaceae (Mallow family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/76Salicaceae (Willow family), e.g. poplar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/882Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2020563279A 2018-12-27 2019-12-24 変性エラスチンの分解低下の抑制剤、正常なエラスチン線維の維持剤、エラスチン-エラフィン複合体形成抑制剤及びエラスチン-エラフィン複合体形成抑制作用を有する物質のスクリーニング方法 Active JP7663359B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023060120A JP2023078477A (ja) 2018-12-27 2023-04-03 変性エラスチンの分解低下の抑制剤、正常なエラスチン線維の維持剤、エラスチン-エラフィン複合体形成抑制剤及びエラスチン-エラフィン複合体形成抑制作用を有する物質のスクリーニング方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018245318 2018-12-27
JP2018245318 2018-12-27
PCT/JP2019/050479 WO2020138023A1 (ja) 2018-12-27 2019-12-24 変性エラスチンの分解低下の抑制剤、正常なエラスチン線維の維持剤、エラスチン-エラフィン複合体形成抑制剤及びエラスチン-エラフィン複合体形成抑制作用を有する物質のスクリーニング方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023060120A Division JP2023078477A (ja) 2018-12-27 2023-04-03 変性エラスチンの分解低下の抑制剤、正常なエラスチン線維の維持剤、エラスチン-エラフィン複合体形成抑制剤及びエラスチン-エラフィン複合体形成抑制作用を有する物質のスクリーニング方法

Publications (2)

Publication Number Publication Date
JPWO2020138023A1 JPWO2020138023A1 (ja) 2021-10-21
JP7663359B2 true JP7663359B2 (ja) 2025-04-16

Family

ID=71125747

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020563279A Active JP7663359B2 (ja) 2018-12-27 2019-12-24 変性エラスチンの分解低下の抑制剤、正常なエラスチン線維の維持剤、エラスチン-エラフィン複合体形成抑制剤及びエラスチン-エラフィン複合体形成抑制作用を有する物質のスクリーニング方法
JP2023060120A Pending JP2023078477A (ja) 2018-12-27 2023-04-03 変性エラスチンの分解低下の抑制剤、正常なエラスチン線維の維持剤、エラスチン-エラフィン複合体形成抑制剤及びエラスチン-エラフィン複合体形成抑制作用を有する物質のスクリーニング方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023060120A Pending JP2023078477A (ja) 2018-12-27 2023-04-03 変性エラスチンの分解低下の抑制剤、正常なエラスチン線維の維持剤、エラスチン-エラフィン複合体形成抑制剤及びエラスチン-エラフィン複合体形成抑制作用を有する物質のスクリーニング方法

Country Status (10)

Country Link
US (1) US20220062159A1 (enExample)
EP (1) EP3903885A4 (enExample)
JP (2) JP7663359B2 (enExample)
KR (1) KR20210109556A (enExample)
CN (1) CN113316472A (enExample)
AU (1) AU2019417521A1 (enExample)
CA (1) CA3120845A1 (enExample)
SG (1) SG11202105579VA (enExample)
TW (1) TWI887225B (enExample)
WO (1) WO2020138023A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7500380B2 (ja) * 2020-10-05 2024-06-17 株式会社ナリス化粧品 皮膚光老化予防改善剤のスクリーニング方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005343887A (ja) 2004-05-28 2005-12-15 Kao Corp エラスターゼ阻害剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3583108B2 (ja) * 2002-03-14 2004-10-27 株式会社ノエビア 皮膚外用剤
JP2004182687A (ja) * 2002-12-05 2004-07-02 Kao Corp エラスターゼ阻害剤
JP5057638B2 (ja) 2003-11-27 2012-10-24 共栄化学工業株式会社 皮膚外用剤
JP4939766B2 (ja) * 2005-04-13 2012-05-30 株式会社 資生堂 基底膜安定化剤
US20110038814A1 (en) * 2007-08-27 2011-02-17 Emilie Rogg-Le Claire Tryptase inhibiting mustard extract
JP5970148B2 (ja) * 2008-09-12 2016-08-17 丸善製薬株式会社 チロシナーゼ活性阻害剤、メラニン産生抑制剤、及びSCFmRNA発現抑制剤
GB0902040D0 (en) * 2009-02-06 2009-03-11 Seeds Lp Composition for treatment of skin
CN102670423A (zh) * 2011-03-14 2012-09-19 日本乐敦制药株式会社 弹性蛋白酶活性抑制剂
JP5878714B2 (ja) * 2011-09-15 2016-03-08 一丸ファルコス株式会社 リンパ管腔形成促進剤
CA2896646A1 (en) * 2012-12-27 2014-07-03 Hayashibara Co., Ltd. Skin-exterior anti-ageing composition and production method therefor
JP6244594B2 (ja) * 2013-03-12 2017-12-13 株式会社東洋新薬 老化抑制剤
FR3010906B1 (fr) * 2013-09-25 2016-12-23 Expanscience Lab Extrait lipidique de graines de passiflores
IL259007B2 (en) * 2016-08-17 2024-07-01 Orthogen Ag Anti-ageing pharmaceutical preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005343887A (ja) 2004-05-28 2005-12-15 Kao Corp エラスターゼ阻害剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
川上晋平, パセノールTMの肌への作用, FOOD STYLE 21, 2016, Vol.20, No.3, pp.58-60

Also Published As

Publication number Publication date
JPWO2020138023A1 (ja) 2021-10-21
JP2023078477A (ja) 2023-06-06
SG11202105579VA (en) 2021-07-29
EP3903885A4 (en) 2022-10-12
AU2019417521A1 (en) 2021-06-17
EP3903885A1 (en) 2021-11-03
TW202038984A (zh) 2020-11-01
CN113316472A (zh) 2021-08-27
WO2020138023A1 (ja) 2020-07-02
KR20210109556A (ko) 2021-09-06
US20220062159A1 (en) 2022-03-03
TWI887225B (zh) 2025-06-21
CA3120845A1 (en) 2020-07-02

Similar Documents

Publication Publication Date Title
JP5361820B2 (ja) グルタチオン増強用組成物
JP5538611B2 (ja) メイラード反応阻害剤
WO2007148737A1 (ja) 植物抽出物の調製方法、並びに植物抽出物及びその用途
JP4286513B2 (ja) 抗老化用組成物
JP2025010230A (ja) ネムノキ抽出物含有組成物
JP2020147527A (ja) ヒアルロン酸産生促進剤および保湿剤、コラーゲン産生促進剤および抗シワ剤、細胞賦活化剤、ならびに、メラニン産生抑制剤および美白剤
JP7663359B2 (ja) 変性エラスチンの分解低下の抑制剤、正常なエラスチン線維の維持剤、エラスチン-エラフィン複合体形成抑制剤及びエラスチン-エラフィン複合体形成抑制作用を有する物質のスクリーニング方法
WO2018124002A1 (ja) プロテインl-イソアスパラギン酸メチルトランスフェラーゼ活性化用組成物
CN111447937B (zh) 作为自噬促进剂的协同组合物
KR101914441B1 (ko) 퓨코스테롤을 유효성분으로 포함하는 피부 보습용 화장료 조성물
JP5694728B2 (ja) 細胞間接着剤
JP6122200B1 (ja) 抗糖化用組成物
JP7642607B2 (ja) 皮膚バリア機能の低下抑制又は改善用組成物、4型コラーゲンの発現の低下抑制又は改善用組成物及び皮膚バリア機能の低下抑制又は改善作用を有する物質のスクリーニング方法
CN110248641A (zh) 包含丝胶、蛇床子提取物及槲寄生提取物的皮肤再生、皮肤舒缓或伤口愈合用组合物
HK40057873A (en) Agent for inhibiting reduction in decomposition of denatured elastin, agent for maintaining normal elastin fibers, agent for inhibiting formation of elastin-elafine composite, and screening method for substance having elastin-elafine composite formation inhibitory effect
JP5412798B2 (ja) 最終糖化産物の生成抑制剤、化粧料および飲食品
JP2017171638A (ja) 骨強度改善剤
JP7408269B2 (ja) メラノソーム分解促進剤
JP2015160843A (ja) 糖化反応阻害剤
JP2017088553A (ja) 抗糖化剤
JP2021075504A (ja) 抗糖化剤
JP2023176943A (ja) オクルディン産生促進剤、クローディン-1産生促進剤、クローディン-4産生促進剤及びバリア機能亢進剤
JP2024077153A (ja) オートファジー活性化剤
JP2023102984A (ja) Endo180産生促進剤
KR20220161400A (ko) 변성 엘라스틴의 분해 저하의 억제제, 정상적인 엘라스틴 섬유의 유지제, 엘라스틴-엘라핀 복합체 형성 억제제 및 이들을 포함하는 조성물

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210528

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220607

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220802

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221004

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230104

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20230403

C116 Written invitation by the chief administrative judge to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C116

Effective date: 20230418

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20230418

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250214

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250404

R150 Certificate of patent or registration of utility model

Ref document number: 7663359

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150